# Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT02872090** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 42 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Glycopyrronium
- **DRUG:** Tiotropium
- **DRUG:** Placebo
- **PROCEDURE:** photoplethysmography

## Key facts

- **NCT ID:** NCT02872090
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872090, "Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02872090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
